Skip to main content
. 2022 Mar 21;12:856974. doi: 10.3389/fonc.2022.856974

Figure 5.

Figure 5

Novel upcoming strategies to reverse bCSC drug resistance. (A) Cartoon structure of a nanoparticle-based drug carrier encapsulated with multiple chemotherapeutic drugs targeting bCSC antigens. (B) α- or β-emitting radionuclide conjugated with monoclonal antibody targeting breast CSC-specific antigens. (C) Design of oncolytic viral particles targeting tumor cells. (D) Cartoon representation of chimeric antigen receptor (CAR-T therapy) against CSC surface antigens.